These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 37321954)

  • 1. Evaluation of Multiparametric MRI Radiomics-Based Nomogram in Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Two-Center study.
    Wang X; Hua H; Han J; Zhong X; Liu J; Chen J
    Clin Breast Cancer; 2023 Aug; 23(6):e331-e344. PubMed ID: 37321954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of radiomics based on CE-MRI for predicting the efficacy of neoadjuvant chemotherapy in invasive breast cancer.
    Li Q; Huang Y; Xiao Q; Duan S; Wang S; Li J; Niu Q; Gu Y
    Br J Radiol; 2022 Oct; 95(1139):20220186. PubMed ID: 36005646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomic signatures derived from multiparametric MRI for the pretreatment prediction of response to neoadjuvant chemotherapy in breast cancer.
    Bian T; Wu Z; Lin Q; Wang H; Ge Y; Duan S; Fu G; Cui C; Su X
    Br J Radiol; 2020 Nov; 93(1115):20200287. PubMed ID: 32822542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric MRI-based radiomics nomogram for early prediction of pathological response to neoadjuvant chemotherapy in locally advanced gastric cancer.
    Li J; Yin H; Wang Y; Zhang H; Ma F; Li H; Qu J
    Eur Radiol; 2023 Apr; 33(4):2746-2756. PubMed ID: 36512039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics of contrast-enhanced spectral mammography for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer.
    Zhang K; Lin J; Lin F; Wang Z; Zhang H; Zhang S; Mao N; Qiao G
    J Xray Sci Technol; 2023; 31(4):669-683. PubMed ID: 37066960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative prediction of axillary sentinel lymph node burden with multiparametric MRI-based radiomics nomogram in early-stage breast cancer.
    Zhang X; Yang Z; Cui W; Zheng C; Li H; Li Y; Lu L; Mao J; Zeng W; Yang X; Zheng J; Shen J
    Eur Radiol; 2021 Aug; 31(8):5924-5939. PubMed ID: 33569620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Combined Nomogram Model for Predicting the Pathological Complete Response to Neoadjuvant Chemotherapy in Invasive Breast Carcinoma of No Specific Type: Real-World Study.
    Zhu X; Shen J; Zhang H; Wang X; Zhang H; Yu J; Zhang Q; Song D; Guo L; Zhang D; Zhu R; Wu J
    Front Oncol; 2022; 12():916526. PubMed ID: 35734603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
    Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a nomogram based on pretreatment dynamic contrast-enhanced MRI for the prediction of pathologic response after neoadjuvant chemotherapy for triple-negative breast cancer.
    Li Y; Chen Y; Zhao R; Ji Y; Li J; Zhang Y; Lu H
    Eur Radiol; 2022 Mar; 32(3):1676-1687. PubMed ID: 34767068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Apparent Diffusion Coefficient Maps for a Radiomics Nomogram to Predict Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.
    Chen X; Chen X; Yang J; Li Y; Fan W; Yang Z
    J Comput Assist Tomogr; 2020; 44(2):275-283. PubMed ID: 32004189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics nomogram for predicting axillary lymph node metastasis in breast cancer based on DCE-MRI: A multicenter study.
    Zhang J; Zhang Z; Mao N; Zhang H; Gao J; Wang B; Ren J; Liu X; Zhang B; Dou T; Li W; Wang Y; Jia H
    J Xray Sci Technol; 2023; 31(2):247-263. PubMed ID: 36744360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
    Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
    World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram for Early Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Using Dynamic Contrast-enhanced and Diffusion-weighted MRI.
    Zhao R; Lu H; Li YB; Shao ZZ; Ma WJ; Liu PF
    Acad Radiol; 2022 Jan; 29 Suppl 1():S155-S163. PubMed ID: 33593702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of neoadjuvant chemotherapy pathological complete response for breast cancer based on radiomics nomogram of intratumoral and derived tissue.
    Zheng G; Hou J; Shu Z; Peng J; Han L; Yuan Z; He X; Gong X
    BMC Med Imaging; 2024 Jan; 24(1):22. PubMed ID: 38245712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A predictive nomogram for individualized recurrence stratification of bladder cancer using multiparametric MRI and clinical risk factors.
    Xu X; Wang H; Du P; Zhang F; Li S; Zhang Z; Yuan J; Liang Z; Zhang X; Guo Y; Liu Y; Lu H
    J Magn Reson Imaging; 2019 Dec; 50(6):1893-1904. PubMed ID: 30980695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-center study of a combined nomogram based on mammography and MRI to predict ALN metastasis in breast cancer.
    Hua Y; Peng Q; Han J; Fei J; Sun A
    Magn Reson Imaging; 2024 Jul; 110():128-137. PubMed ID: 38631535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric MRI-based radiomics analysis for prediction of breast cancers insensitive to neoadjuvant chemotherapy.
    Xiong Q; Zhou X; Liu Z; Lei C; Yang C; Yang M; Zhang L; Zhu T; Zhuang X; Liang C; Liu Z; Tian J; Wang K
    Clin Transl Oncol; 2020 Jan; 22(1):50-59. PubMed ID: 30977048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using radiomics of pretreatment dynamic contrast-enhanced MRI.
    Yoshida K; Kawashima H; Kannon T; Tajima A; Ohno N; Terada K; Takamatsu A; Adachi H; Ohno M; Miyati T; Ishikawa S; Ikeda H; Gabata T
    Magn Reson Imaging; 2022 Oct; 92():19-25. PubMed ID: 35636571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric MRI-based radiomics nomogram for predicting the hormone receptor status of HER2-positive breast cancer.
    Sang L; Liu Z; Huang C; Xu J; Wang H
    Clin Radiol; 2024 Jan; 79(1):60-66. PubMed ID: 37838543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinicopathological-imaging nomogram for the prediction of pathological complete response in breast cancer cases administered neoadjuvant therapy.
    Yang W; Yang Y; Zhang C; Yin Q; Zhang N
    Magn Reson Imaging; 2024 Sep; 111():120-130. PubMed ID: 38703971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.